Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease
Orly Leiva, Siyang Ren, Donna Neuberg, Ankeet S. Bhatt, Andrew Jenkins, Rachel Rosovsky, Rebecca Karp Leaf, Katayoon Goodarzi, Gabriela Hobbs
Topics & Concepts
MedicineInternal medicineCardiologyPulmonary hypertensionHazard ratioAtrial fibrillationMyocardial infarctionHeart failureCause of deathBlood pressureDiseaseConfidence intervalPulmonary Hypertension Research and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and Syndromes